Hui Yin Lim

593 total citations
56 papers, 399 citations indexed

About

Hui Yin Lim is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Hui Yin Lim has authored 56 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Internal Medicine, 24 papers in Cardiology and Cardiovascular Medicine and 23 papers in Hematology. Recurrent topics in Hui Yin Lim's work include Venous Thromboembolism Diagnosis and Management (28 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Atrial Fibrillation Management and Outcomes (14 papers). Hui Yin Lim is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (28 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Atrial Fibrillation Management and Outcomes (14 papers). Hui Yin Lim collaborates with scholars based in Australia, Malaysia and Singapore. Hui Yin Lim's co-authors include Prahlad Ho, Harshal Nandurkar, Geoffrey A. Donnan, Mark Tacey, Cindy J. O’Malley, Jeffrey D. Zajac, Ada S. Cheung, Chong Chyn Chua, Jill Keeffe and Patricia O’Connor and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and European Heart Journal.

In The Last Decade

Hui Yin Lim

46 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Yin Lim Australia 12 144 122 107 47 41 56 399
Luuk J.J. Scheres Netherlands 18 356 2.5× 247 2.0× 265 2.5× 56 1.2× 94 2.3× 41 795
Josh Benner United States 3 38 0.3× 23 0.2× 119 1.1× 39 0.8× 56 1.4× 3 575
A. L. Svendsen Denmark 8 103 0.7× 121 1.0× 83 0.8× 59 1.3× 85 2.1× 10 636
Paul Vulliamy United Kingdom 14 39 0.3× 59 0.5× 43 0.4× 97 2.1× 144 3.5× 30 578
Caterina Bressi Italy 10 89 0.6× 241 2.0× 107 1.0× 29 0.6× 91 2.2× 16 463
Francesco Del Sole Italy 9 138 1.0× 31 0.3× 182 1.7× 65 1.4× 86 2.1× 13 446
Luigi Pacifico United States 11 388 2.7× 84 0.7× 296 2.8× 64 1.4× 154 3.8× 21 550
Odile Stalder Switzerland 12 84 0.6× 18 0.1× 82 0.8× 44 0.9× 52 1.3× 39 357
Anna Klajnbard Denmark 6 74 0.5× 174 1.4× 65 0.6× 14 0.3× 61 1.5× 12 485
J. Debeij Netherlands 9 128 0.9× 70 0.6× 59 0.6× 25 0.5× 164 4.0× 12 435

Countries citing papers authored by Hui Yin Lim

Since Specialization
Citations

This map shows the geographic impact of Hui Yin Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Yin Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Yin Lim more than expected).

Fields of papers citing papers by Hui Yin Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Yin Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Yin Lim. The network helps show where Hui Yin Lim may publish in the future.

Co-authorship network of co-authors of Hui Yin Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Yin Lim. A scholar is included among the top collaborators of Hui Yin Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Yin Lim. Hui Yin Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nandurkar, Harshal, et al.. (2025). Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes. Journal of Thrombosis and Thrombolysis. 58(3). 391–400. 1 indexed citations
2.
Nelson, David P., Stacey L Rowe, F. Ha, et al.. (2024). Global and national insights into the decline of hypertrophic cardiomyopathy as a cause of sudden death in the young. European Heart Journal. 45(Supplement_1).
3.
Wang, Julie, et al.. (2024). Spontaneous bleeding in chronic kidney disease: global coagulation assays may predict bleeding risk. Research and Practice in Thrombosis and Haemostasis. 8(5). 102520–102520.
4.
5.
Leung, P. C., et al.. (2024). A 12-Year Review of Upper Extremity Deep Vein Thrombosis—Are They the Same as Lower Extremity Deep Vein Thrombosis?. Journal of Clinical Medicine. 13(21). 6440–6440. 1 indexed citations
6.
Brown, Jason, et al.. (2023). Complete Pacing Lead Fracture in Subclavian Crush Syndrome. Heart Lung and Circulation. 32. S275–S275.
7.
Lim, Hui Yin, et al.. (2023). DOAC‐stop can remove direct oral anticoagulants and allow analysis by global coagulation assays. International Journal of Laboratory Hematology. 45(3). 360–367. 2 indexed citations
8.
Lim, Hui Yin, Mark Tacey, David Barit, et al.. (2023). Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk. Thrombosis Research. 226. 127–135. 9 indexed citations
9.
Ho, Prahlad, et al.. (2022). Management of venous thromboembolism in morbidly obese patients: a 10-year review. Journal of Thrombosis and Thrombolysis. 55(2). 304–311. 4 indexed citations
10.
Lim, Hui Yin, et al.. (2022). The Need for Individualized Risk Assessment in Cardiovascular Disease. Journal of Personalized Medicine. 12(7). 1140–1140. 7 indexed citations
11.
Lim, Hui Yin, et al.. (2021). Global coagulation assays in patients with diabetes mellitus. Research and Practice in Thrombosis and Haemostasis. 5(7). e12611–e12611. 14 indexed citations
12.
Lim, Hui Yin, et al.. (2020). Assessing maternal clotting function with novel global coagulation assays: A prospective pilot study. International Journal of Laboratory Hematology. 43(3). 458–467. 5 indexed citations
13.
Cheung, Ada S., Hui Yin Lim, Teddy Cook, et al.. (2020). Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals. The Journal of Clinical Endocrinology & Metabolism. 106(3). 893–901. 34 indexed citations
14.
Lim, Hui Yin, et al.. (2018). An evaluation of global coagulation assays in myeloproliferative neoplasm. Blood Coagulation & Fibrinolysis. 29(3). 300–306. 13 indexed citations
15.
Chua, Chong Chyn, Hui Yin Lim, Khai Li Chai, et al.. (2018). Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma. Bone Marrow Transplantation. 53(9). 1116–1123. 11 indexed citations
16.
Lim, Hui Yin, Chong Chyn Chua, Mark Tacey, et al.. (2017). Venous thromboembolism management in Northeast Melbourne: how does it compare to international guidelines and data?. Internal Medicine Journal. 47(9). 1034–1042. 8 indexed citations
17.
Lim, Hui Yin, et al.. (2016). Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events. Journal of Thrombosis and Thrombolysis. 42(3). 423–431. 10 indexed citations
18.
Lim, Hui Yin, et al.. (2014). Red Herring in Returned Traveler: Drug Reaction With Eosinophilia and Systemic Symptom (DRESS) Syndrome Mimicking Sepsis. Journal of Travel Medicine. 21(6). 425–428. 4 indexed citations
19.
Lim, Hui Yin, David Francis, Jonathan Yeoh, & Lyndell L. Lim. (2013). CYTOMEGALOVIRUS RETINITIS AFTER TREATMENT WITH LENALIDOMIDE FOR MULTIPLE MYELOMA. Retinal Cases & Brief Reports. 7(2). 172–175. 5 indexed citations
20.
Lim, Hui Yin, Patricia O’Connor, & Jill Keeffe. (2007). Low vision services provided by optometrists in Victoria, Australia. Clinical and Experimental Optometry. 91(2). 177–182. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luuk J.J. Scheres Breakdown of academic impact, for papers by Josh Benner Breakdown of academic impact, for papers by A. L. Svendsen Breakdown of academic impact, for papers by Paul Vulliamy Breakdown of academic impact, for papers by Caterina Bressi Breakdown of academic impact, for papers by Francesco Del Sole Breakdown of academic impact, for papers by Luigi Pacifico Breakdown of academic impact, for papers by Odile Stalder Breakdown of academic impact, for papers by Anna Klajnbard Breakdown of academic impact, for papers by J. Debeij
Rankless by CCL
2026